Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Drugs. This report contains market size and forecasts of Gastrointestinal Cancer Drugs in global, including the following market information:
Global Gastrointestinal Cancer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastrointestinal Cancer Drugs Market Sales, 2018-2023, 2024-2029, (g)
Global top five Gastrointestinal Cancer Drugs companies in 2022 (%)
The global Gastrointestinal Cancer Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oncology Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastrointestinal Cancer Drugs include Amgen & Amgen Ireland, Bristol-Myers Squibb Company, Roche, Eli Lilly and Company, Johnson & Johnson Private, GlaxoSmithKline, Celgene Corporation, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastrointestinal Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Cancer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (g)
Global Gastrointestinal Cancer Drugs Market Segment Percentages, by Type, 2022 (%)
Oncology
Radiology
Others
Global Gastrointestinal Cancer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (g)
Global Gastrointestinal Cancer Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
Global Gastrointestinal Cancer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (g)
Global Gastrointestinal Cancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Cancer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastrointestinal Cancer Drugs revenues share in global market, 2022 (%)
Key companies Gastrointestinal Cancer Drugs sales in global market, 2018-2023 (Estimated), (g)
Key companies Gastrointestinal Cancer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen & Amgen Ireland
Bristol-Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Cancer Drugs, market overview.
Chapter 2: Global Gastrointestinal Cancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastrointestinal Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastrointestinal Cancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Cancer Drugs Overall Market Size
2.1 Global Gastrointestinal Cancer Drugs Market Size: 2022 VS 2029
2.2 Global Gastrointestinal Cancer Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastrointestinal Cancer Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gastrointestinal Cancer Drugs Players in Global Market
3.2 Top Global Gastrointestinal Cancer Drugs Companies Ranked by Revenue
3.3 Global Gastrointestinal Cancer Drugs Revenue by Companies
3.4 Global Gastrointestinal Cancer Drugs Sales by Companies
3.5 Global Gastrointestinal Cancer Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastrointestinal Cancer Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastrointestinal Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Cancer Drugs Market Size Markets, 2022 & 2029
4.1.2 Oncology
4.1.3 Radiology
4.1.4 Others
4.2 By Type - Global Gastrointestinal Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Cancer Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Gastrointestinal Cancer Drugs Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Cancer Drugs Sales, 2018-2023
4.3.2 By Type - Global Gastrointestinal Cancer Drugs Sales, 2024-2029
4.3.3 By Type - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Gastrointestinal Cancer Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Cancer Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialized Cancer Treatment Centers
5.1.4 Clinics
5.1.5 Ambulatory Surgical Centers
5.2 By Application - Global Gastrointestinal Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Cancer Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Gastrointestinal Cancer Drugs Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Cancer Drugs Sales, 2018-2023
5.3.2 By Application - Global Gastrointestinal Cancer Drugs Sales, 2024-2029
5.3.3 By Application - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Gastrointestinal Cancer Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Gastrointestinal Cancer Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gastrointestinal Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Cancer Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Gastrointestinal Cancer Drugs Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Cancer Drugs Sales, 2018-2023
6.3.2 By Region - Global Gastrointestinal Cancer Drugs Sales, 2024-2029
6.3.3 By Region - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Gastrointestinal Cancer Drugs Revenue, 2018-2029
6.4.2 By Country - North America Gastrointestinal Cancer Drugs Sales, 2018-2029
6.4.3 US Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.4.4 Canada Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.4.5 Mexico Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Cancer Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Gastrointestinal Cancer Drugs Sales, 2018-2029
6.5.3 Germany Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.4 France Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.5 U.K. Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.6 Italy Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.7 Russia Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.5.9 Benelux Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Cancer Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Gastrointestinal Cancer Drugs Sales, 2018-2029
6.6.3 China Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.6.4 Japan Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.6.5 South Korea Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.6.7 India Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Gastrointestinal Cancer Drugs Revenue, 2018-2029
6.7.2 By Country - South America Gastrointestinal Cancer Drugs Sales, 2018-2029
6.7.3 Brazil Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.7.4 Argentina Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Cancer Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Gastrointestinal Cancer Drugs Sales, 2018-2029
6.8.3 Turkey Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.8.4 Israel Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gastrointestinal Cancer Drugs Market Size, 2018-2029
6.8.6 UAE Gastrointestinal Cancer Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen & Amgen Ireland
7.1.1 Amgen & Amgen Ireland Company Summary
7.1.2 Amgen & Amgen Ireland Business Overview
7.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Major Product Offerings
7.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen & Amgen Ireland Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Gastrointestinal Cancer Drugs Major Product Offerings
7.3.4 Roche Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Major Product Offerings
7.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly and Company Key News & Latest Developments
7.5 Johnson & Johnson Private
7.5.1 Johnson & Johnson Private Company Summary
7.5.2 Johnson & Johnson Private Business Overview
7.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Major Product Offerings
7.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Private Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Major Product Offerings
7.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Celgene Corporation Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Gastrointestinal Cancer Drugs Major Product Offerings
7.8.4 Pfizer Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Gastrointestinal Cancer Drugs Major Product Offerings
7.9.4 Sanofi Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Gastrointestinal Cancer Drugs Major Product Offerings
7.10.4 Novartis Gastrointestinal Cancer Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
8 Global Gastrointestinal Cancer Drugs Production Capacity, Analysis
8.1 Global Gastrointestinal Cancer Drugs Production Capacity, 2018-2029
8.2 Gastrointestinal Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Cancer Drugs Supply Chain Analysis
10.1 Gastrointestinal Cancer Drugs Industry Value Chain
10.2 Gastrointestinal Cancer Drugs Upstream Market
10.3 Gastrointestinal Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastrointestinal Cancer Drugs in Global Market
Table 2. Top Gastrointestinal Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastrointestinal Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastrointestinal Cancer Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gastrointestinal Cancer Drugs Sales by Companies, (g), 2018-2023
Table 6. Global Gastrointestinal Cancer Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastrointestinal Cancer Drugs Price (2018-2023) & (USD/g)
Table 8. Global Manufacturers Gastrointestinal Cancer Drugs Product Type
Table 9. List of Global Tier 1 Gastrointestinal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastrointestinal Cancer Drugs Sales (g), 2018-2023
Table 15. By Type - Global Gastrointestinal Cancer Drugs Sales (g), 2024-2029
Table 16. By Application ? Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastrointestinal Cancer Drugs Sales (g), 2018-2023
Table 20. By Application - Global Gastrointestinal Cancer Drugs Sales (g), 2024-2029
Table 21. By Region ? Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastrointestinal Cancer Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastrointestinal Cancer Drugs Sales (g), 2018-2023
Table 25. By Region - Global Gastrointestinal Cancer Drugs Sales (g), 2024-2029
Table 26. By Country - North America Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastrointestinal Cancer Drugs Sales, (g), 2018-2023
Table 29. By Country - North America Gastrointestinal Cancer Drugs Sales, (g), 2024-2029
Table 30. By Country - Europe Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastrointestinal Cancer Drugs Sales, (g), 2018-2023
Table 33. By Country - Europe Gastrointestinal Cancer Drugs Sales, (g), 2024-2029
Table 34. By Region - Asia Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastrointestinal Cancer Drugs Sales, (g), 2018-2023
Table 37. By Region - Asia Gastrointestinal Cancer Drugs Sales, (g), 2024-2029
Table 38. By Country - South America Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastrointestinal Cancer Drugs Sales, (g), 2018-2023
Table 41. By Country - South America Gastrointestinal Cancer Drugs Sales, (g), 2024-2029
Table 42. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Sales, (g), 2018-2023
Table 45. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Sales, (g), 2024-2029
Table 46. Amgen & Amgen Ireland Company Summary
Table 47. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Offerings
Table 48. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 49. Amgen & Amgen Ireland Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Offerings
Table 52. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Gastrointestinal Cancer Drugs Product Offerings
Table 56. Roche Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Gastrointestinal Cancer Drugs Product Offerings
Table 60. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. Johnson & Johnson Private Company Summary
Table 63. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Offerings
Table 64. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 65. Johnson & Johnson Private Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Gastrointestinal Cancer Drugs Product Offerings
Table 68. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Celgene Corporation Company Summary
Table 71. Celgene Corporation Gastrointestinal Cancer Drugs Product Offerings
Table 72. Celgene Corporation Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 73. Celgene Corporation Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Gastrointestinal Cancer Drugs Product Offerings
Table 76. Pfizer Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Gastrointestinal Cancer Drugs Product Offerings
Table 80. Sanofi Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Gastrointestinal Cancer Drugs Product Offerings
Table 84. Novartis Gastrointestinal Cancer Drugs Sales (g), Revenue (US$, Mn) and Average Price (USD/g) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Gastrointestinal Cancer Drugs Production Capacity (g) of Key Manufacturers in Global Market, 2021-2023 (g)
Table 87. Global Gastrointestinal Cancer Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Gastrointestinal Cancer Drugs Production by Region, 2018-2023 (g)
Table 89. Global Gastrointestinal Cancer Drugs Production by Region, 2024-2029 (g)
Table 90. Gastrointestinal Cancer Drugs Market Opportunities & Trends in Global Market
Table 91. Gastrointestinal Cancer Drugs Market Drivers in Global Market
Table 92. Gastrointestinal Cancer Drugs Market Restraints in Global Market
Table 93. Gastrointestinal Cancer Drugs Raw Materials
Table 94. Gastrointestinal Cancer Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Gastrointestinal Cancer Drugs Downstream
Table 96. Gastrointestinal Cancer Drugs Downstream Clients in Global Market
Table 97. Gastrointestinal Cancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal Cancer Drugs Segment by Type in 2022
Figure 2. Gastrointestinal Cancer Drugs Segment by Application in 2022
Figure 3. Global Gastrointestinal Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Cancer Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastrointestinal Cancer Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastrointestinal Cancer Drugs Sales in Global Market: 2018-2029 (g)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal Cancer Drugs Revenue in 2022
Figure 9. By Type - Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastrointestinal Cancer Drugs Price (USD/g), 2018-2029
Figure 13. By Application - Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastrointestinal Cancer Drugs Price (USD/g), 2018-2029
Figure 17. By Region - Global Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 23. US Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 37. China Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastrointestinal Cancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastrointestinal Cancer Drugs Production Capacity (g), 2018-2029
Figure 53. The Percentage of Production Gastrointestinal Cancer Drugs by Region, 2022 VS 2029
Figure 54. Gastrointestinal Cancer Drugs Industry Value Chain
Figure 55. Marketing Channels
